UNSPSC 51131631: Dabigatran

This classification denotes an anticoagulant agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier I0VM4M70GC. European Medicines Agency schedules Dabigatran in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB25417. Dabigatran generally arises in the molecular formula C25H25N7O3. The term DABIGATRAN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 15 no. 3-4, 2001, list 46.) Most nations schedule dabigatran under HS 29333999 and SITC 51574.

As of Q4 2014, DABIGATRAN remains the US FDA Preferred Term for this commodity. Dabigatran bears US NLM identifiers UMLS ID C2348066 and NCI Concept Code C73224. SMILES: O=C(N(CCC(=O)O)C1NCCCC1)C1CC2NC(N(C2CC1)C)CNC1CCC(CC1)C(=N)N.

UNSPSC 51131631 Dabigatran, a Commodity code, does not align with recent state and local procurement activity. Dabigatran is an anticoagulant pharmaceutical product; the single recent opportunity tagged under this code—Sourcewell's RFP #061626 for law enforcement equipment—addresses police and security gear entirely unrelated to pharmaceutical procurement or medical supply chains.

The mismatch suggests either a cataloging error in the originating database or a misapplication of the UNSPSC code to the solicitation. State and local governments do procure pharmaceuticals through group purchasing organizations and cooperative vehicles, but the available source material shows no relevant recent activity under this specific code. The law enforcement equipment RFP, issued by Sourcewell (a Minnesota local government unit and service cooperative) on behalf of participating entities in Washington state and across the United States and Canada with response due June 16, 2026, falls outside the pharmaceutical scope and does not support a meaningful assessment of dabigatran procurement patterns or market opportunity in the state and local sector.